Elsevier's "ScienceDirect" Articles S...
AMSTERDAM, The Netherlands, July 14 /PRNewswire/ --
- Platform's Online Content Doubled in Less Than Five Years
Elsevier, a leading publisher of scientific, technical and medical (STM)
information, today announced that its online scientific research platform,
ScienceDirect, has surpassed nine million full-text articles.
Doubling its content in less than five years, ScienceDirect is the
largest and most extensive online STM research platform. Serving the evolving
needs of the global scientific community, the platform offers search,
reference and discovery tools to help researchers quickly find the most
relevant content for their specific objectives.
"The increasing volume and quality of articles on ScienceDirect continues
to make it a high-value asset to the scientific community," said Rafael Sidi,
Vice President, Product Management, ScienceDirect. "The platform's ability to
help find and harness specific knowledge within the growing pool of content
is critical."
The nine millionth article added to ScienceDirect was On the Origin of a
Double Oblique Impact of Mars by J. E. Chappelow and R. R. Herrick of Arctic
Region Supercomputing Center at University of Alaska Fairbanks. The study,
which appears in the journal Icarus, explores how Mars' Olympus Mons, the
largest volcano in the Solar System, was formed.
"I'm happy to participate in this exciting milestone," said Chappelow.
"The growing reach of online articles opens up new opportunities for
collaboration, which have helped many researchers to advance their fields of
science. My own research has benefited from the multiple contacts I've made
as a result of online literature searches."
ScienceDirect serves as host to the scientific research community by
creating "peer connections" between scientists and researchers and fostering
interactions that allow them to compare and discuss findings and accelerate
research. Recent enhancements to the platform also include 2collab, a new
collaboration tool that researchers can use to rate and comment on research
articles.
About ScienceDirect
Over a quarter of the world's full text scientific, technical and medical
(STM) peer-reviewed articles - managed by renowned editors, written by
respected authors and read by researchers from around the globe - are
available in one place: ScienceDirect.
Elsevier's extensive and unique full-text collection covers authoritative
titles from the core scientific literature including high impact factor
titles such as THE LANCET, Cell and Tetrahedron. Over nine million articles
are available online, including Articles in Press which offer online access
to recently accepted manuscripts. The critical mass of trusted information
available on ScienceDirect is unsurpassed. Coverage includes over 2,500
journals published by Elsevier and dynamic linking to journals from
approximately 2,000 STM publishers through CrossRef. An expanding program of
online major reference works, handbooks, book series and over 4,400 eBooks in
all fields of science seamlessly interlinks with primary research referenced
in journal articles.
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical
information products and services. Working in partnership with the global
science and health communities, Elsevier's 7,000 employees in over 70 offices
worldwide publish more than 2,000 journals and 1,900 new books per year, in
addition to offering a suite of innovative electronic products, such as
ScienceDirect (http://www.sciencedirect.com/), MD Consult (
http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/),
bibliographic databases, and online reference works.
Elsevier (http://www.elsevier.com/) is a global business headquartered in
Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of
Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading
publisher and information provider. Operating in the science and medical,
legal, education and business-to-business sectors, Reed Elsevier provides
high-quality and flexible information solutions to users, with increasing
emphasis on the Internet as a means of delivery. Reed Elsevier's ticker
symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and
ENL (New York Stock Exchange).
Contact:
Malkie Bernheim
Padilla Speer Beardsley
+1-212-752-8338 ext. 662
mbernheim@psbpr.com